Rockmont Investments

EvidenceCare, LLC is a company that designs and develops decision support tools and web applications for clinicians, aimed at enhancing the delivery of medical care and treatment procedures. Established in 2014 and based in Brentwood, Tennessee, EvidenceCare offers a clinical decision support system (CDSS) that integrates seamlessly into a clinician's electronic health record (EHR) workflow. This platform provides customized, interactive guidance to healthcare providers, promoting evidence-based care with measurable outcomes. Key features of EvidenceCare include Pathway Builder, which allows health systems to create tailored care pathways; Admission Criteria, designed to minimize denial rates and maximize reimbursements for hospitals; and Imaging Criteria, which ensures compliance with appropriate use criteria for advanced imaging services. By leveraging advanced CDSS technology, EvidenceCare helps healthcare organizations improve quality and safety, reduce liability, enhance operational efficiency, and capture additional revenue while adhering to government compliance requirements.

MiNDERA Corporation specializes in the development of non-invasive molecular testing devices aimed at diagnosing skin cancer and other skin diseases. The company's innovative products include a micro-needle array patch that allows for pain-free and minimally invasive extraction of biomarkers such as RNA, DNA, and proteins from the skin, eliminating the need for traditional skin biopsies. Additionally, MiNDERA is working on a whole transcriptome extraction patch and a skin microbiome extraction patch for various research applications. Founded in 2013, the company is headquartered in Palo Alto, California.